Not finding it? Sign in to also search OpenAlex live.
-
A prospective, randomized, controlled, double-blind, multi-center study to evaluate the efficacy and safety of a blue light device for the treatment of chronic back pain2024 Frontiers in Pain Research article Medicine Laser Applications in Dentistry and Medicine Open access
Ralf Baron, Bart J. Morlion, Albert Dahan, Michael A. Überall, Golo von Basum, Imane Wild
4citations -
Rethinking clinical trials in the multimorbidity era: the imperative for patient-centered tailored approaches2026 Journal of Clinical Epidemiology review Medicine Chronic Disease Management Strategies Open access
Ana Isabel González‐González, Elisa Fabbri, Lara Schürmann, Jeanet W. Blom, Svetlana Puzhko, Amaia Calderón‐Larrañaga, +14 more
3citations -
Efficacy of Fremanezumab in Male Patients With Migraine and Documented Inadequate Response to 2–4 Classes of Migraine Preventive Medication Classes: Results of the Randomized, Placebo-controlled FOCUS Study (4339)
Antoinette MaassenVanDenBrink, Gisela Marie Terwindt, Joshua M. Cohen, Ronghua Yang, Verena Ramirez-Campos, Maja Galić, +2 more
0citations -
OP0227 EFFICACY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE TYROSINE KINASE 2 INHIBITOR, IN MUSCULOSKELETAL MANIFESTATIONS OF ACTIVE PSORIATIC ARTHRITIS IN A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL2021 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments cited by 1 patent
Philip J. Mease, Atul A. Deodhar, Désirée van der Heijde, Frank Behrens, Alan Kivitz, Thomas Lehman, +3 more
3citations -
CANNA-TICS: Efficacy and Safety of Oral Treatment with Nabiximols in Adults with Chronic Tic Disorders – Results of a Prospective, Multicenter, Randomized, Double-Blind, Placebo Controlled, Phase IIIb Superiority Study2023 SSRN Electronic Journal preprint Psychology Obsessive-Compulsive Spectrum Disorders Open access
Kirsten Müller‐Vahl, Anna Pisarenko, Natalia Szejko, Martina Haas, Carolin Fremer, Ewgeni Jakubovski, +10 more
2citations -
AB0403 INFLUENCE OF BODY WEIGHT, SEX AND PRIOR BIOLOGIC HISTORY ON TREATMENT OUTCOMES ASSOCIATED WITH TAK-279, A HIGHLY SELECTIVE ORAL TYROSINE KINASE 2 (TYK2) INHIBITOR, IN A PHASE 2B RANDOMIZED TRIAL IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS2024 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments
L. Eder, Elena Tomaselli Muensterman, Désirée van der Heijde, A. Kivitz, Muhammad Rehman, J. Chen, +1 more
1citations -
OP0103 DOES GENDER, AGE OR SUBPOPULATION INFLUENCE THE MAINTENANCE OF CLINICAL REMISSION IN AXIAL SPONDYLOARTHRITIS FOLLOWING CERTOLIZUMAB PEGOL DOSE REDUCTION?2020 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
R. B. M. Landewé, Désirée M F M van der Heijde, Maxime Dougados, Xenofon Baraliakos, Filip E Van den Bosch, Karl Gaffney, +5 more
1citations -
Unterschiede in HbA1c-senkender Wirkung und Hypoglykämierisiko zwischen Insulin glargin 300 E/ml (Gla-300) und Insulin degludec 100 E/ml (IDeg) je nach Nierenfunktion in der BRIGHT-Studie
Martin Haluzı́k, Athena Philis‐Tsimikas, Zsolt Bosnyák, Dirk Müller‐Wieland, Felipe Lauand, Lydie Melas‐Melt, +2 more
0citations -
POS0205 SAFETY AND TOLERABILITY OF NINTEDANIB IN PATIENTS WITH AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASES (ILDs) IN SUBGROUPS BY SEX AND AGE2022 Annals of the Rheumatic Diseases conference-abstract Medicine Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Open access
A. M. Hoffmann-Vold, E. Volkmann, Yannick Allanore, S. Assassi, Jeska de Vries‐Bouwstra, V. Smith, +4 more
0citations -
Effet du sécukinumab versus adalimumab biosimilaire sur la progression radiographique chez les patients atteints de spondyloarthrite axiale radiographique : analyse en sous-groupes avec sur le statut syndesmophytes et protéine C-réactive à l’inclusion
Christian Hubert Roux, Denis Poddubnyy, Désirée M F M van der Heijde, D. Atul, Pedro Machado, Victoria Navarro‐Compán, +13 more
0citations -
The Effect of Systemic Hydrocortisone Initiated 7 to 14 Days After Birth in Ventilated Preterm Infants on Mortality and Neurodevelopment at 2 Years’ Corrected Age: Follow-Up of a Double-Blind, Placebo-Controlled, Multicentre, Randomised Trial
Nienke Marjolein Halbmeijer, Wes Onland, Filip Cools, Renate M. C. Swarte, Marja van der Heide-Jalving, Maruschka P. Merkus, +15 more
0citations -
Faible activité et rémission sous filgotinib [FIL] chez les patients PR ayant présenté une réponse inadéquate aux bDMARDs: analyse en sous-groupes de l’étude de phase 3 FINCH2
Jacques‐Eric Gottenberg, Maya H Buch, Roberto Felice Caporali, KENNETH C. KALUNIAN, Alena Pechonkina, Shijia Rao, +3 more
0citations -
PEMBROLIZUMAB VS PLACEBO PLUS PACLITAXEL WITH OR WITHOUT BEVACIZUMAB FOR PLATINUM-RESISTANT RECURRENT OVARIAN CANCER: RESULTS BY HISTOLOGIC SUBTYPE FROM THE PHASE 3 ENGOT-OV65/KEYNOTE-B96 STUDY2026 International Journal of Gynecological Cancer article Medicine Ovarian cancer diagnosis and treatment
Nicoletta Colombo, Emese Zsíros, Al Covens, Radosław Mądry, Pamela Salman, Mihai Meirovitz, +14 more
0citations -
POS1046 IMPROVEMENTS IN PATIENT-REPORTED IMPACT OF PSORIATIC ARTHRITIS WITH IL-12/23 (USTEKINUMAB) OR TUMOUR NECROSIS FACTOR INHIBITORS: 1-YEAR DATA FROM THE LARGE, REAL-WORLD PsABIO STUDY2021 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Laure Gossec, Stefan Siebert, Paul Bergmans, Kurt de Vlam, Elisa Gremese, Beatriz E. Joven-Ibáñez, +6 more
0citations -
Efficacité et tolérance d’upadacitinib chez des patients atteints de spondylarthrite ankylosante et ayant eu une intolérance et/ou un manque d’efficacité lors d’un traitement antérieur par biologique : analyse en sous-groupes
Xenofon Baraliakos, Fabiana Ganz, Hideto Kameda, Jessica A. Walsh, Manish Jain, K. D'silva, +5 more
0citations